FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3194961566> ?p ?o ?g. }

• W3194961566 endingPage "989" @default.
• W3194961566 startingPage "989" @default.
• W3194961566 abstract "The administration of probiotics via live feeds, such as Artemia and rotifers, has gained significant attention. Moreover, indiscriminate use of antibiotics in conventional aquaculture practices in order to prevent or control disease outbreaks has resulted in the occurrence of residues and antimicrobial resistance. Thus, the application of eco-friendly feed additives, such as probiotics, as a safer alternative has received increasing attention in recent years. However, only minimal information on the administration of probiotics via freshwater cladoceran Moina micrura is available despite being commonly used for larval and post-larval feeding of freshwater crustaceans and fish. Thus, this study aimed to evaluate the application of Bacillus pocheonensis strain S2 administered via M. micrura to red hybrid tilapia (Oreochromis spp.) larvae. Bacillus pocheonensis that has been previously isolated from Spirulina sp. was subjected to preliminary in vitro evaluation of antagonistic properties. The agar well-diffusion assay revealed that this probiont could inhibit the growth of Streptococcus agalactiae and Aeromonas hydrophila. The size of inhibition zones ranged from 8.8 ± 0.2 to 18.2 ± 0.4 mm. Moina micrura was later used as a biological model in preliminary in vivo bacterial challenge assays to evaluate the efficacy of B. pocheonensis in protecting the host from diseases. Moina micrura was pre-enriched with B. pocheonensis at 104 and 106 CFU mL−1 before S. agalactiae and A. hydrophila were introduced into the culture. The study revealed that B. pocheonensis at 104 CFU mL−1 was able to significantly enhance the survival of M. micrura after being challenged with both pathogens (63 ± 3%) in comparison to the control group. The relative percentage survival (RPS) of M. micrura was highest (p < 0.05) when treated with B. pocheonensis at both concentrations 104 and 106 CFU mL−1 (38.33) after being challenged against S. agalactiae. To assess the efficacy of B. pocheonensis in protecting red hybrid tilapia against streptococcosis, the larvae were fed with either unenriched (control) Moina or probiont-enriched Moina daily for 10 days. A significantly (p < 0.05) higher survival rate (77 ± 3%) was observed in larvae fed with probiont-enriched M. micrura compared to other treatments, and the RPS was recorded at 62.90. In addition, the S. agalactiae load was suppressed in larvae fed probiont-enriched M. micrura (6.84±0.39 CFU mL−1) in comparison to the control group (7.78±0.09 CFU mL−1), indicating that the probiont might have contributed to the improvement of tilapia health and survival. This study illustrated that M. micrura was suitable to be used as a vector for probiotics in freshwater fish larvae as an alternative to hazardous antibiotics for disease control." @default.
• W3194961566 created "2021-08-30" @default.
• W3194961566 creator A5010828275 @default.
• W3194961566 creator A5013020503 @default.
• W3194961566 creator A5044622509 @default.
• W3194961566 creator A5051607798 @default.
• W3194961566 date "2021-08-16" @default.
• W3194961566 modified "2023-10-11" @default.
• W3194961566 title "The Efficacy of Moina micrura Enriched with Probiotic Bacillus pocheonensis in Enhancing Survival and Disease Resistance of Red Hybrid Tilapia (Oreochromis spp.) Larvae" @default.
• W3194961566 cites W1704456421 @default.
• W3194961566 cites W1966135113 @default.
• W3194961566 cites W1978742851 @default.
• W3194961566 cites W1981604073 @default.
• W3194961566 cites W1985463592 @default.
• W3194961566 cites W1997066596 @default.
• W3194961566 cites W1997497703 @default.
• W3194961566 cites W2001105478 @default.
• W3194961566 cites W2010702101 @default.
• W3194961566 cites W2011177952 @default.
• W3194961566 cites W2013607514 @default.
• W3194961566 cites W2016070424 @default.
• W3194961566 cites W2031971000 @default.
• W3194961566 cites W2045106889 @default.
• W3194961566 cites W2048589426 @default.
• W3194961566 cites W2049664535 @default.
• W3194961566 cites W2059235491 @default.
• W3194961566 cites W2068926246 @default.
• W3194961566 cites W2073350446 @default.
• W3194961566 cites W2079102266 @default.
• W3194961566 cites W2090797369 @default.
• W3194961566 cites W2092369541 @default.
• W3194961566 cites W2122712356 @default.
• W3194961566 cites W2136733151 @default.
• W3194961566 cites W2139731480 @default.
• W3194961566 cites W2150774960 @default.
• W3194961566 cites W2160767207 @default.
• W3194961566 cites W2168044487 @default.
• W3194961566 cites W2540232486 @default.
• W3194961566 cites W2611684314 @default.
• W3194961566 cites W2790712567 @default.
• W3194961566 cites W2793406470 @default.
• W3194961566 cites W2793556844 @default.
• W3194961566 cites W2811034075 @default.
• W3194961566 cites W2887364476 @default.
• W3194961566 cites W2888719726 @default.
• W3194961566 cites W2899956321 @default.
• W3194961566 cites W2904708331 @default.
• W3194961566 cites W2913209293 @default.
• W3194961566 cites W2930406957 @default.
• W3194961566 cites W2953847423 @default.
• W3194961566 cites W2969217144 @default.
• W3194961566 cites W2971343801 @default.
• W3194961566 cites W3012542474 @default.
• W3194961566 cites W3027724027 @default.
• W3194961566 cites W3087983376 @default.
• W3194961566 cites W3093550526 @default.
• W3194961566 cites W3094613264 @default.
• W3194961566 cites W3099598218 @default.
• W3194961566 cites W3117035318 @default.
• W3194961566 cites W3120240332 @default.
• W3194961566 cites W3147814433 @default.
• W3194961566 cites W4212851690 @default.
• W3194961566 doi "https://doi.org/10.3390/antibiotics10080989" @default.
• W3194961566 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8388897" @default.
• W3194961566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34439039" @default.
• W3194961566 hasPublicationYear "2021" @default.
• W3194961566 type Work @default.
• W3194961566 sameAs 3194961566 @default.
• W3194961566 citedByCount "5" @default.
• W3194961566 countsByYear W31949615662022 @default.
• W3194961566 countsByYear W31949615662023 @default.
• W3194961566 crossrefType "journal-article" @default.
• W3194961566 hasAuthorship W3194961566A5010828275 @default.
• W3194961566 hasAuthorship W3194961566A5013020503 @default.
• W3194961566 hasAuthorship W3194961566A5044622509 @default.
• W3194961566 hasAuthorship W3194961566A5051607798 @default.
• W3194961566 hasBestOaLocation W31949615661 @default.
• W3194961566 hasConcept C2777860557 @default.
• W3194961566 hasConcept C2778276568 @default.
• W3194961566 hasConcept C2778658382 @default.
• W3194961566 hasConcept C2779286987 @default.
• W3194961566 hasConcept C2779441561 @default.
• W3194961566 hasConcept C2780255968 @default.
• W3194961566 hasConcept C2909208804 @default.
• W3194961566 hasConcept C31903555 @default.
• W3194961566 hasConcept C505870484 @default.
• W3194961566 hasConcept C523546767 @default.
• W3194961566 hasConcept C54355233 @default.
• W3194961566 hasConcept C86803240 @default.
• W3194961566 hasConcept C86909935 @default.
• W3194961566 hasConcept C89423630 @default.
• W3194961566 hasConceptScore W3194961566C2777860557 @default.
• W3194961566 hasConceptScore W3194961566C2778276568 @default.
• W3194961566 hasConceptScore W3194961566C2778658382 @default.
• W3194961566 hasConceptScore W3194961566C2779286987 @default.
• W3194961566 hasConceptScore W3194961566C2779441561 @default.
• W3194961566 hasConceptScore W3194961566C2780255968 @default.
• W3194961566 hasConceptScore W3194961566C2909208804 @default.

• next